anesthesiology

Remimazolam Besylate Matches Propofol for Short-Term ICU Sedation: The SHOSREB Trial

The SHOSREB trial demonstrates that remimazolam besylate is non-inferior to propofol for short-term light sedation in mechanically ventilated ICU patients, with both agents achieving 97.5% successful sedation rates and comparable time withi

Wearable TEAS Outperforms Metoclopramide in Managing Moderate to Severe Postoperative Nausea and Vomiting